We investigated the effects of ethinylestradiol dose (50, 30 and 20 μg) and progestogen type
[desogestrel (DSG), gestodene (GSD), levonorgestrel (LNG) and norgestimate (NGM)] in …

Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Previous discussions have indicated that the small increases of risk of venous
thromboembolism (VTE) associated with newer combined oral contraceptives (third …

A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

This review provides an update of knowledge regarding venous thromboembolism (VTE)
and combined hormonal contraceptives (CHCs) in the light of new progestins and new …

The risk of venous thrombosis (VT) varies according to the type of progestogen that is found
in combined oral contraceptives (COCs). When combined with the estrogen component …

Purpose Recent studies showed differences in the risk of venous thrombosis between
different combined hormonal contraceptives. Database studies comprising large cohorts can …

Objective To determine the effect of oestrogen dose and progestogen type on the
coagulation and fibrinolytic systems of a group of normal healthy women taking three …

Current users of combined oral contraceptives have an increased risk of venous
thromboembolism. The risk appears to be higher during the first year of use and disappears …